Ogilvy adds biotech to its capabilities with Feinstein purchase
NEW YORK: Ogilvy continued its buying spree last week with the acquisition of Cambridge, MA-based Feinstein Kean Partners, a healthcare and biotech agency with annual billings in excess of dollars 9 million.
Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>